InsidersTradesSigma
Follow the RNV share price and the full insider trade history of the company, a listed equity based in Australia. Shares are listed on the AU market, under the oversight of ASX. Operating in the Health Care sector, RNV has published 1 public disclosures. Market capitalisation: €12.9m. The latest transaction was reported on 29 April 2026 (Other). Among the most active insiders: Dr David Rhodes. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
RNV is a company operating in the healthcare and pharmaceutical sector, listed on the XASX market.